These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27483259)

  • 1. Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?
    Pap A; Cuaranta-Monroy I; Peloquin M; Nagy L
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
    Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
    Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR gamma and human metabolic disease.
    Semple RK; Chatterjee VK; O'Rahilly S
    J Clin Invest; 2006 Mar; 116(3):581-9. PubMed ID: 16511590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multifaceted factor peroxisome proliferator-activated receptor γ (PPARγ) in metabolism, immunity, and cancer.
    Kim JH; Song J; Park KW
    Arch Pharm Res; 2015 Mar; 38(3):302-12. PubMed ID: 25579849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm.
    Cock TA; Houten SM; Auwerx J
    EMBO Rep; 2004 Feb; 5(2):142-7. PubMed ID: 14755307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma: a critical determinant of body fat distribution in humans and mice.
    Tsai YS; Maeda N
    Trends Cardiovasc Med; 2005 Apr; 15(3):81-5. PubMed ID: 16039966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PPARgamma coding region and its role in visceral obesity.
    Boon Yin K; Najimudin N; Muhammad TS
    Biochem Biophys Res Commun; 2008 Jun; 371(2):177-9. PubMed ID: 18413145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
    Sharma AM; Staels B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ.
    Wang X; Liu J; Long Z; Sun Q; Liu Y; Wang L; Zhang X; Hai C
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):286-96. PubMed ID: 26408789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
    Toyama K; Nakamura T; Kataoka K; Yasuda O; Fukuda M; Tokutomi Y; Dong YF; Ogawa H; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):508-13. PubMed ID: 21679694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma: the more the merrier?
    Argmann CA; Cock TA; Auwerx J
    Eur J Clin Invest; 2005 Feb; 35(2):82-92; discussion 80. PubMed ID: 15667578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
    Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
    Nagy ZS; Czimmerer Z; Szanto A; Nagy L
    Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat and beyond: the diverse biology of PPARgamma.
    Tontonoz P; Spiegelman BM
    Annu Rev Biochem; 2008; 77():289-312. PubMed ID: 18518822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes.
    Li G; Leff T
    Mol Endocrinol; 2007 Apr; 21(4):857-64. PubMed ID: 17227883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of transcription factor PPARγ and C/EBP family members during in vitro adipogenesis of human bone marrow mesenchymal stem cells.
    Zhao XY; Chen XY; Zhang ZJ; Kang Y; Liao WM; Yu WH; Xiang AP
    Cell Biol Int; 2015 Apr; 39(4):457-65. PubMed ID: 25523390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma and metabolic disease.
    Willson TM; Lambert MH; Kliewer SA
    Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor.
    Dobrian AD
    Vascul Pharmacol; 2006 Jul; 45(1):36-45. PubMed ID: 16716756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.